Noteworthy, animal experiments have shown that MET can inhibit NLRP3 inflammasome activation by suppressing mitochondrial ATP and DNA synthesis, protecting mice against LPS-induced acute respiratory distress syndrome (ARDS) and attenuating pulmonary inflammation in COVID-19-infected mice25. This evidence concerns the gene NLRP3 and COVID-19.